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EthR is a mycobacterial repressor that limits the bioactivation of ethionamide, a commonly used anti-tuberculosis second-line drug. Several efforts have been deployed to identify EthR inhibitors abolishing the DNA-binding activity of the repressor. This led to the demonstration that stimulating the bioactivation of Eth through EthR inhibition could be an alternative way to fight Mycobacterium tuberculosis. We propose a new surface plasmon resonance (SPR) methodology to study the affinity between inhibitors and EthR. Interestingly, the binding between inhibitors and immobilized EthR produced a dose-dependent negative SPR signal. We demonstrate that this signal reveals the affinity of small molecules for the repressor. The affinity constants (K D ) correlate with their capacity to inhibit the binding of EthR to DNA. We hypothesize that conformational changes in EthR during ligand interaction could be responsible for this SPR signal. Practically, this unconventional result opens perspectives onto the development of an SPR assay that would at the same time reveal structural changes in the target upon binding with an inhibitor and the binding constant of this interaction.
Tuberculosis is one of the most frightening illnesses on the planet. There were an estimated 8.6 million new TB 1 cases in 2012, including 1.1 million cases among people infected with HIV, and 1.3 million people died from TB that year [1] . Next to HIV infection, demographic factors, poor living conditions, and neglected TB control in many countries caused this pandemic. There is an urgent need for new drugs and new strategies to eliminate more efficiently sensitive or drug-resistant strains. We have recently validated the mycobacterial transcriptional repressor EthR as a new target to fight tuberculosis. EthR belongs to the TetR/CamR family of transcriptional regulators and negatively regulates the expression of ethA in Mycobacterium tuberculosis [2] . The ethA gene encodes a flavin-containing monooxygenase that catalyzes the bioactivation of ethionamide, one of the most commonly used anti-TB second-line drugs [3, 4] .
We have shown that in vitro and in vivo allosteric inhibition of the interaction between EthR and the ethA promoter with a druglike compound was able to improve ethionamide efficacy, which in mice allowed for a therapeutic dose reduction [5] [6] [7] . In the past few years, several efforts have been made to identify and optimize EthR inhibitors [5] [6] [7] [8] [9] [10] . To that end, interactions between EthR and synthetic inhibitors have been studied using a large panel of biological and biophysical assays such as X-ray crystallography [7] , thermal shift assay detecting the thermostabilization effect of the ligand on the protein [8, 11] , and finally surface plasmon resonance (SPR) [2, [5] [6] [7] .
Using the SPR biosensor assay, the interaction between biomolecules immobilized on a sensor surface and biomolecules or small chemical entities flowing over the chip in an aqueous buffer is quantified by measuring variations in refractive index. Interactions on the gold surface of the biosensor chip between two partners increase the electron density around the sensor surface and in most cases induce positive changes in the refractive index, translated as a real-time SPR signal called a sensorgram (resonance unit as function of time) [12] . SPR is an ideal tool to generate high-quality data on the interactions between biomolecules, as well as between small ligands and biomolecules. Direct binding assay based on SPR presents many advantages: it is label-free, has a low target consumption, and provides real time analysis and detection of low-affinity target binders [13] .
As an efficient tool to study inhibitors of EthR, we previously designed a bioanalytical assay based on SPR. SPR was used to measure the capacity of inhibitors to disturb the interaction between EthR and its DNA operator (DNA/EthR SPR methodology) [2, [5] [6] [7] . Although very useful to quantify the capacity of EthR ligand to inhibit the DNA binding function of EthR, this approach was unsuitable for revealing the binding constants that drive the direct interactions between EthR and the inhibitors, which allowed only fragmentary comparisons between compounds. Then, to further characterize our EthR inhibitors by accessing binding constants (K D ), we immobilized the transcriptional repressor EthR on a CM5 carboxymethylated sensor chip and monitored the interaction with EthR inhibitors in solution (ligand/EthR SPR methodology). We report here an SPR assay focusing on the direct ligand/ transcriptional repressor interactions to compare chemical series of new EthR inhibitors. This assay produced unconventional negative SPR signals that we demonstrate to be specific for the ligand/ protein interaction. We discuss the hypothesis that this signal could be predictive of the allosteric structural changes undergone during ligand/protein interaction and examine the implications of this observation in the context of target-based drug screening.
Materials and methods
SPR experiments were carried on a BIAcore 3000 instrument (GE HealthCare). Thermal shift assay (TSA) experiments were performed on a LightCycler 480 instrument (Roche). Research-grade CM5, SA (streptavidin), and NTA (nitrilotriacetic acid) sensors were purchased from GE HealthCare. HBS-EP (10 mM Hepes, 150 mM NaCl, 3 mM EDTA, 0.005% surfactant P20) was purchased from GE HealthCare and used with various sodium chloride concentrations. All chemicals used (Tris-HCl, NaCl, EDTA, DTT (dithiothreitol), NHS (N-hydroxysuccinimide), EDC (N-ethyl-N 0 -(3-diethylaminopropyl)carbodiimide hydrochloride), ethanolamine, and Sypro orange) were of the highest grade available commercially.
Plasmid construction and His 6 -EthR and His 6 -EthR-mutant expression and purification

Construction of plasmid pET-15b-ethR
The N-terminally hexahistidine-tagged EthR was produced in Escherichia coli C41 (pET-15b-ethR) and purified as described. The DNA coding for EthR was amplified by PCR using M. tuberculosis H37Rv chromosomal DNA as template and oligonucleotides O-183, 5 0 -CATATGACCACCTCCGCGGCCAGT-3 0 , and O-184, 5 0 -GGAT CCGAGCACCCCCGACCGAGT-3 0 , as primers. The PCR product was inserted into pCR2.1Topo (Invitrogen) to generate pCR2.1-ethR. The EthR-encoding fragment was sequenced on both strands and then isolated from pCR2.1-ethR by digestion with NdeI and BamHI and inserted into pET-15b (Novagen), yielding pET-15b-ethR. This plasmid encodes EthR containing an extra amino-terminal tag with the following sequence: MGSSH 6 SSGLVPRGSHM.
Construction of plasmid pET-15b-ethR G106W
A first PCR product was obtained by amplification using M. tuberculosis H37Rv chromosomal DNA as template and oligonucleotides O-275 (5 0 -AGGACCGTCCGCTGGCCGATA-3 0 ) and O-276 (5 0 -AACA CGTTGATCCAGGTGCGCCACA-3 0 ) as primers, thus introducing a point mutation at codon 106 of ethR (underlined in oligonucleotide O-276), resulting in the replacement of glycine 106 by a tryptophan residue. This 216-bp fragment was used as a 5 0 primer in association with oligonucleotide O-278 (5 0 -GCTTCCTTTCGGGCTTTGTTAGCAG-3 0 ) to amplify a 594-bp fragment, which was subsequently inserted into PCRII-Topo (Invitrogen) to generate pCRIIethRG106W. The 275-bp SalI-SalI fragment of pET-15b-ethR [2] was then exchanged for the equivalent fragment of pCRIIethRG106W to produce pET-15b-ethR G106W . The orientation of the fragment was checked by restriction digestion and the DNA sequence was confirmed by sequencing of the entire open reading frame.
Production and purification of His 6 -EthR and mutant His 6 -EthR G106W N-terminally hexahistidine-tagged EthR WT or G106W was produced in E. coli C41 using the protein expression plasmids pET-15b-ethR and pET-15b-ethR G106W , respectively, as previously described [2] . Bacteria were grown in 100 ml LB broth to an OD 600 nm of 0.6-0.7. Isopropylthiogalactoside was then added to a final concentration of 1 mM and the culture was grown for 3 h. The cells were harvested by centrifugation at 12,000g at 4°C, resuspended in 10 ml of lysis buffer (50 mM Tris-HCl, 300 mM NaCl, pH 7.5, 10 mM imidazole), and lysed by two passages at 6.2 MPa through a French press cell. After centrifugation (20,000g, 25 min, 4°C), the supernatant was recovered and His 6 -EthR or His 6 -EthR G106W was separated from the whole-cell lysate by Ni-NTA agarose chromatography (Qiagen). After three washing steps with lysis buffer, His 6 -tagged proteins were eluted from the resin with 250 mM imidazole in lysis buffer, dialyzed overnight against EthR buffer (10 mM Tris-HCl, 300 mM NaCl, pH 7.5, 1 mM DTT, 0.1 mM EDTA), and concentrated to 14 mg/ml for EthR and 7 mg/ml for EthR G106W . Protein purity was controlled by Coomassie blue staining after SDS-PAGE on a 12% polyacrylamide gel. Protein concentration was evaluated using the Bio-Rad protein assay kit. Purified proteins His 6 -EthR and His 6 -EthR G106W were stored in EthR buffer at 4°C.
Production of biotinylated double-stranded DNA fragments
The 106-bp fragment overlapping the ethA-R intergenic region (DNA etha-r ) was obtained from M. tuberculosis H37Rv chromosomal DNA using O-270, 5 0 -CGGTCATGGATCCACGCTATCAAC-3 0 , and O-271, 5 0 -biotin-CTGACTGGCCGCGGAGGTGGT-3 0 . The biotinylated double-stranded 113-bp-long irrelevant DNA fragment (+14 to +127) of the E. coli bla gene was PCR amplified using oligonucleotides O-343, 5 0 -TTTCCGTGTCGCCCTTATTCC-3 0 , and O-344, 5 0 -CCAC TCGTGCACCCAACTGAT-3 0 , and pUC18 as substrate (DNA nonspecific ). The amplified biotinylated fragments were purified on a QiaQuick column (Qiagen), cloned, and sequenced.
SPR assay for determining EthR/ligand affinity
Immobilization of EthR and EthR G106W on CM5 sensor chip
All SPR experiments were performed at 25°C. Capture of EthR and EthR G106W was performed on CM5 sensor chips with a carboxymethylated dextran matrix using an HBS-EP running buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% surfactant P20). The chip was first activated by injecting a fresh mixture (35 ll, 50/50, v/v) of 0.1 mM NHS and 0.4 mM EDC at a flow rate of 5 ll/min. Several 5-ll injections of EthR or EthR G106W , respectively at 15 and 30 lg/ml, in 10 mM acetate buffer, pH 4.5, were performed so as to reach the desired level of covalently attached protein (1000, 2000, 4000, 7000, or 10000 resonance units (RU)). Noncovalently bound esters were deactivated by injection of 35 ll of 1 M ethanolamine hydrochloride, pH 8.5, followed by a surface wash with a 0.03% SDS solution.
Real-time binding experiment for EthR/ligand interaction on CM5
Binding experiments were performed with a constant flow rate of 20 ll/min using HBS-EP buffer (10 mM Hepes, 350 mM NaCl, 0.005% surfactant P20, 3 mM EDTA, 1% Me 2 SO) as the running buffer. Experiments were performed on a CM5 sensor functionalized with 4000 RU of EthR G106W on the reference flow cell (F1) and with the equivalent amount of EthR on the analysis flow cell (F2). Ligands were injected at atleast six different concentrations over both channels. The range of concentrations was selected from 0, 0.1, 0.33, 1, 3, 6, 9, 27, 60, 81, 121, 243 lM, depending on the solubility of the ligand (visual test in the running buffer) and on the minimal concentration necessary to observe a signal. All experiments were repeated at least three times and each concentration was tested in triplicate. The final sample concentration of Me 2 SO was 1%. The samples were injected over 2, 5, 9, or 16 min. The injection time was chosen so as to observe the equilibrium state for at least two concentrations. As all the ligands were able to dissociate from the protein during the course of the running buffer on the surface, we avoided injection of a regeneration solution to preserve the sensor chip. Dissociation times up to 20 min were applied to recover the initial baseline level between injections of the various ligands at increasing concentrations. This dissociation time was increased as long as necessary for high-affinity ligands such as BDM41907 and BDM44831. The binding sensorgrams were obtained from the subtraction F2ÀF1.
Data analysis for K D determination
For all the ligands studied the K D was determined using the following method: the sensorgrams were analyzed using BIAevaluation software version 4.0.1. As the software cannot interpret a negative sensorgram, the curves were mirrored by multiplication of the data by À1. Subtraction of a blank sensorgram, obtained by injecting ligand buffer, was performed before each series of analysis to correct for bulk effect and other systematic artifacts. The corresponding data were fitted using all concentrations simultaneously and both association and dissociation curves were fitted simultaneously. For all ligands analyzed, the one-to-one Langmuir model provided adequate fitting. In the following equation, A represents the analyte in solution, B the protein immobilized, and AB the complex formed by the interaction on the chip:
AB:
The adequateness of the fit was judged by the values of the v 2 (lower than 5% of the R max ) and the randomness of residue distribution. The association rate constant (k on ) and the dissociation rate constant (k off ) were derived from the optimal binding model using BIAevaluation software. The dissociation constant K D was calculated based on the ratio of k off /k on .
K D calculated from RU values at the equilibrium state
For the fit validation, some K D values were also extrapolated from graph with the response (RU) at the equilibrium state as a function of the ligand concentration. Normalization, fit, and detection of the inflection point of the curves were performed using GraphPad Prism 5.0. to determine K D values. the standard protocol provided by BIAcore (GE HealthCare). Injection of 5 ll of a 500 lM NiCl 2 solution was performed to load Ni 2+ ions on the surface and activate the NTA sensor chip. Injection of 20 ll of a 150 nM solution of EthR in running buffer was performed to achieve a signal of 2700 RU. Eight minutes after EthR immobilization (necessary for baseline stabilization), the ligands were injected over channels F1 and F2 during 4 min so as to observe the equilibrium state. After 10 min of dissociation, the surface was flushed with 5 ll of solution W (10 mM Hepes, 150 mM NaCl, 0.35 M EDTA, 0.005% surfactant P20) to remove all protein from the surface. Activation, immobilization, analysis, and regeneration cycle were performed for each ligand analysis. The oriented capture of EthR on the surface of the NTA sensor chip allows slow and continuous dissociation of the protein, resulting in a nonhorizontal baseline. To take this phenomenon into account, subtraction from the same flow cell of a buffer injection completed before ligand analysis was systematically performed. Using this technique, we obtained horizontal baselines that allowed comparison of NTA and CM5 analysis. However, because of this continuous EthR dissociation, NTA sensor chips were not used for K D determination.
SPR analysis of ligand/EthR interaction on NTA sensor chip
SPR assay for determining the inhibition of EthR/DNA binding by ligands
Immobilization of biotinylated double-stranded EthA promoter On sensor chip SA with preimmobilized streptavidin, irrelevant and relevant DNA fragments were immobilized on channels F1 and F2, respectively. The first channel of the chip (F1) was loaded with a 150 ng/ml biotinylated double-stranded 113-bplong irrelevant DNA fragment at a flow rate of 10 ll/min to obtain 75 RU stable binding to the streptavidin. The 106-bp biotinylated ethA-R DNA intergenic region at 150 ng/ml was injected through the second channel (F2) at a flow rate of 10 ll/min to reach the same 75-RU stable fixation to the streptavidin. The sensor chip was then washed with 0.03% SDS before protein injection. 
IC 50 determination
Binding of EthR to the immobilized DNA was measured at 25°C in 10 mM Tris-HCl (pH 7.5), 200 mM NaCl, 0.1 mM EDTA, 1 mM DTT, and 1% Me 2 SO at a flow rate of 20 ll/min. SA sensor chips immobilized with 75 RU of specific and nonspecific DNA fragments were used for the analysis. A specific interaction (SI) between EthR and the 106-bp DNA fragment was defined as the signal difference between both channels (F2ÀF1). Six different concentrations, between 25.4 nM and 500 lM, were used for IC 50 determination. Successive dilutions of the initial compound solution were performed in the binding buffer to obtain the desired final concentrations containing 1% in Me 2 SO, incubated 5 min at 37°C in the presence of 540 nM EthR, and injected over the two channels at a flow rate of 20 ll/min for 3 min. EthR to DNA dissociation was achieved by flowing buffer for 20 min on the chip before the next binding measurement. SDS (0.03%) wash was abolished because of low recovery of stable baseline. SI values were measured at the end of the injection period and allowed to calculate each ligand inhibition percentage according to the following ratio:
Percentages of inhibition were plotted as a function of the concentration of the compounds and IC 50 values were determined using a sigmoidal dose-response (variable slope) model from GraphPad Prism 5.0. The IC 50 is the concentration of inhibitor that causes 50% inhibition of EthR binding to DNA.
Thermal shift assay
The thermal shift assay was conducted on a LightCycler 480 system (Roche) in 96-well microplates. To monitor protein unfolding and record the melting temperature of EthR, the protein was heated in the presence of the environmentally sensitive fluorescent dye Sypro orange (Invitrogen). The unfolding process exposes hydrophobic regions of the protein and induces an increase in fluorescence of the dye. To prepare the microplate, 5 ll of the ligand at 60 lM in Tris buffer (50 mM Tris-HCl, 300 mM NaCl, pH 7.5) in the presence of 3% Me 2 SO is introduced into the appropriate wells. The ligand solution is replaced by a 3% Me 2 SO solution in EthR buffer for the negative controls. The EthR/Sypro orange solution (10 ll) is added to all the wells to reach a final concentration of 20 lM in ligand, 10 lM in EthR, 2.5Â in Sypro orange, and 1% in Me 2 SO.
After centrifugation, an incubation time of 30 min is allowed before the analysis. The plate is heated from 37 to 85°C with a heating rate of 0.04°C/s. The fluorescence intensity was measured at 465/510 nm. The fluorescence imaging data obtained from the LightCycler 480 were treated and analyzed with IGOR software. The inflection point of the curves was detected by plotting the first derivative dFI/dT, and the melting temperatures (T m ) were assessed from the maxima.
Results
SPR signal of the EthR/ligand interaction
Developing an SPR assay to detect interactions between small synthetic ligands and EthR on a Biacore 3000 was a real challenge because of the molecular mass of the ligands (between 300 and 500 Da). According to the R max formula [14] , 2000 RU (2000 pg/ mm 2 ) of EthR was covalently immobilized on a CM5 sensor chip. Assuming an expected binding ratio of 1 ligand per EthR monomer, a maximum theoretical response of 28 RU would be expected using a 350-Da ligand. In a first attempt to monitor the ligand-binding propensity of immobilized EthR, we used BDM41907, a ligand known to inhibit with a high efficacy the fixation of the repressor on its DNA operator (IC 50 375 nM). Injected onto the sensor surface functionalized with immobilized EthR, BDM41907 produced an unexpected sensorgram composed exclusively of negative values. However, except for this unanticipated negative profile, the curve showed a classical shape, characterized by a marked and rapid response at the beginning of the injection, followed by a plateau upon continuous injection, and finally the progressive recovering of the initial baseline after injection (Fig. 1) .
The SPR signal is specific for the ligand/EthR interaction and dosedependent
Injections with increasing concentrations of BDM41907 from 0.3 to 81 lM were tested. Results showed highly reproducible dose-dependent negative responses leading to a bona fide plateau, suggesting that the observed signal, although negative, translates interactions between EthR and BDM41907 (Fig. 1) . To assess the specificity of this interaction, we evaluated the capacity of BDM41160, a chemical analogue of BDM41907 previously shown to be inactive as an EthR inhibitor using the TSA or the ''DNA-EthR'' SPR method [5] . Serial injections of increasing concentrations of BDM41160 (from 9 to 243 lM) produced no significant positive nor negative shift of the SPR signal (Fig. 2) . In contrast, dose-dependent negative SPR signals were again observed with the two other well-characterized specific EthR inhibitors BDM31381 [7] and BDM41906 [6] (Fig. 2) .
In a recent work, we designed and characterized a variant of EthR (EthR G106W ) in which the replacement of glycine 106 by a tryptophan was shown to induce a conformation closely related to the conformations of a holo-protein. X-ray crystallography indeed revealed EthR G106W as an apoprotein stabilized in a liganded-like conformation. SPR experiments confirmed that, despite the absence of ligands bound in its pockets, EthR G106W is unable to bind its DNA operator. Finally, isothermal titration calorimetry experiments confirmed the inability of EthR G106W to interact with synthetic ligands [11] , which makes this variant an ideal negative control for the present study. Interestingly, injection of BDM41907 onto a CM5 chip coated with EthR G106W resulted in a complete absence of SPR signal (Fig. 3) .
Altogether, these data strengthened the idea that the SPR dose-dependent negative signal observed with BDM41907 reveals specific interactions with EthR.
Influence of the analytical conditions on the negativity of the SPR signal
To exclude a maximum of possible artifactual effects that could have led to this unusual but specific negative SPR signal [15] , we conducted a series of tests, including the variation of the concentration of the immobilized protein, the roles of Me 2 SO and buffer, and the impact of dextran.
In the first set of experiments, the protein density at the surface of the chip was either reduced (1000 RU) or increased (4000, 7000, 10,000 RU) and BDM41907 was injected at the constant value of 9 lM (Fig. 4) . The negative SPR signal was clearly dependent on the quantity of immobilized protein, suggesting that the negative signal is the consequence of interactions between EthR and ligands.
Deliberate variations in Me 2 SO concentration between running and sample buffers were then tested to evaluate the impact on the refractive index. Injections of buffer were first performed without ligand. The 0.2% difference in Me 2 SO concentration between the mock sample (0.8%) and the running buffer (1%) had a visible impact on the sensorgram (Fig. 5A ). However, the correction using reference subtraction (F2ÀF1) drastically reduced this effect from 200 to 4 RU (Fig. 5B ). Subsequently, solutions of BDM41907 in which Me 2 SO concentration ranged from 0.8% to 1.2% were prepared. These samples were injected on the EthR-bound chips flowed in a running buffer containing 1% Me 2 SO. Classical reference subtraction applied to the various BDM41907 injections almost completely eliminated differences in the response level. Moreover, reproducible signals of the 9 lM ligand injections were obtained despite various differences between the Me 2 SO concentrations in the running buffer versus in the sample buffer (Fig. 5C ).
It has been shown that variations in Me 2 SO concentration can occasionally give rise to large and rapid shifts in refractive index during injection and thus can induce analytical artifacts [16] . Our results revealed no such injection artifacts, suggesting that the negative signal observed upon interaction between EthR and its ligands cannot be attributed to the slight variations in Me 2 SO concentration that may occur in the experiment.
To fully rule out any possible influence of the Me 2 SO in the recorded negative signal, we used BDM41906, which shows a solubility higher than 1 mM in phosphate-buffered saline, to perform the experiment in the absence of Me 2 SO. BDM41906 as a powder was solubilized at 100 lM directly in HBS-EP buffer (HBS-EP-no Me 2 SO) (10 mM Hepes, 150 mM NaCl, 0.005% surfactant P20, 3 mM EDTA). The binding experiment between BDM41906 and EthR was performed on a CM5 sensor functionalized with 4000 RU of EthR G106W on the reference flow cell (F1) and with the equivalent amount of EthR on the analysis flow cell (F2) in the presence of the HBS-EP-no Me 2 SO running buffer. BDM41906 was injected at concentrations ranging from 0.3 to 100 lM on both channels.
As shown in Fig. 5D , a negative, dose-dependent signal was recorded upon injection of the Me 2 SO-free BDM41906 solution, showing that the unconventional signal observed in our previous experiments is unrelated to the presence of Me 2 SO.
It has been reported by some authors that a progressive loss of matter during the run may sometimes result in a decrease in the refractive index. Thus, we investigated the possibility that interaction of EthR and dextran on the chip could decrease upon ligand binding, which would take the protein away from the sensor chip and explain the negative SPR signal. To challenge this hypothesis, we first analyzed a possible competition between free and immobilized dextran. Injections of free dextran on the EthR sensor surface were performed and no variation of the signal was recorded. Then, we showed that injection of free dextran at various concentrations (0.1, 1, and 5 mg/ml) did not modify the binding signal observed with BDM41907. Altogether, these data showed that dextran has no significant affinity for EthR, excluding its capacity to bring the immobilized protein closer to the chip by interacting with it (see sensorgrams in the Supplementary material). Alternatively, one can hypothesize the putative displacement from the chip of a component other than EthR. As the SPR signal returns to the initial value after injection phase, this would imply that such loss would be systematically replaced by a component present in the running buffer. To test this hypothesis, we replaced the initial HBS-EP buffer (used for the continuous flow and for the sample preparation) by Tris buffer. Under these new conditions, the previously observed negative signal was again obtained, thus definitely ruling out the hypothesis of matter displacement.
In addition, the putative influence of electrostatic effect was evaluated by testing a range of NaCl concentrations. Variation of the SPR signal induced by the interactions of EthR and inhibitors was not dependent on salt concentration in the tested range of 150-550 mM NaCl.
We finally tested whether this unconventional SPR signal can be observed independent of the nature of the physicochemical link that attaches EthR onto the chip. In the experiments described so far, EthR had been covalently immobilized to CM5 sensor chips. In this context, EthR was attached to the carboxymethylated dextran matrix using the amine coupling chemical procedure described under Materials and methods. We then tested whether coupling EthR to the sensor chip using a noncovalent capture method would still give negative SPR signal upon ligand binding to the protein. To this purpose, His-tagged EthR was captured in the presence of Ni 2+ ions on carboxymethylated dextran matrix containing immobilized NTA (see Materials and methods). As previously shown for EthR-coated CM5 chips, injections of BDM41907 on NTA chips coated with His-tagged EthR produced a concentration dependent negative variation of the signal associated with an equilibrium state ( Fig. 7) .
Dissociation constant determination
Whereas the physicochemical mechanisms withstanding the negative SPR signal remain to be elucidated, this signal was shown to be ligand-specific and dose-dependent. Other authors previously used such unconventional negative SPR curves to calculate the protein-ligand dissociation constant [17] [18] [19] [20] . We applied this methodology to measure the dissociation constant values of a set of well-characterized EthR ligands. In our experiments, the SPR signal recorded on EthR was systematically subtracted from the signal obtained on the reference EthR G106W -immobilized surface, which drastically reduced all major injection artifacts. Association and dissociation curves obtained after inversion of the negative sensorgrams were fitted using a kinetic Langmuir model 1:1 and led to an acceptable fit residue and v 2 parameters (inferior to 5% of the R max ) (Fig. 6 ). The kinetic parameters were independent of the flow rate, indicating that the binding interaction between inhibitors and EthR was not limited by a mass transport effect. K D values corresponding to the association and dissociation curves obtained are presented in Table 1 . Moreover, no significant variations in K D values were observed using various densities of protein captured on the sensor chip (1000, 2000, and 4000 RU, Table 2 ). K D values obtained from the fitting procedure using the 1:1 binding Langmuir model were compared with K D extrapolated from measures of the resonance unit at the equilibrium state as a function of the ligand concentration (K D at equilibrium, Table 2 ). Both methods reported equivalent values, confirming the validity of the fitting model chosen for K D determination. In previous studies, we have described various methods that inform us directly or indirectly on the capacity of compounds to bind to EthR. The first developed method was a TSA revealing the capacity of compounds to thermostabilize EthR upon binding [8, 11, 21] . A positive shift (DT m ) in the melting temperature of the repressor EthR in the presence of an inhibitor, relative to the T m of the unbound protein, indicates that stabilization of the protein by the compound has occurred. Independent studies have shown that the stabilization of the protein due to ligand binding as revealed by TSA is proportional to the affinity and the concentration of the ligand [22] . The K D 's deduced from the dose-dependent negative SPR signal for 13 synthetic ligands were compared with DT m values obtained by TSA. Results presented in Table 3 show a good correlation with an R 2 of 0.84.
In parallel to the TSA, we previously designed a low-throughput SPR test that measures the capacity of synthetic compounds to impede the binding of EthR to its DNA operator [5] [6] [7] . Our effective EthR inhibitors revealed typical IC 50 in the micro-to the nanomolar range. In Table 3 , for 10 different ligands, we compared pK D obtained by the ligand/EthR SPR test and pIC 50 values deduced from the EthR/DNA SPR test. The obtained correlation factor R 2 of 0.81 indicates that the affinity of the ligands for EthR is correlated with their ability to inhibit the DNA-binding function of EthR.
Discussion
The pivotal second-line anti-tuberculosis drug ethionamide undergoes a process of bioactivation by the monooxygenase EthA [4] , the expression of which is negatively regulated by the TetR-like repressor EthR in M. tuberculosis. It was demonstrated that the basal level of EthR limits the bioactivation of ethionamide and, consequently, participates in an innate form of resistance of M. tuberculosis to this antibiotic. Previous works identified small molecules that inhibit EthR and thus increase ethionamide efficacy [5] [6] [7] [8] 10] .
In these previous studies we developed several biological and biophysical assays to establish strong structure-activity relationships. SPR was used to reveal the capacity of compounds to inhibit EthR/DNA interaction in vitro [5] [6] [7] . It appeared reasonably predictive of the efficacy of the compounds in vivo. However, the DNA/ EthR SPR methodology reflects globally only the equilibrium that encompasses both the binding of ligand to EthR and the binding of EthR to its DNA operator. Although a thermal shift assay was developed to quantify the thermostabilization of EthR by small synthetic ligands [8, 11] , this test did not allow one to determine binding constants. Albeit highly informative of the indirect activity of the compounds at the various biological levels of the cell, all these tests were unsuitable for ranking compounds strictly based on their affinity for the target. To overcome this limitation, we therefore developed a new SPR assay based on the immobilization of the transcriptional repressor on a CM5 sensor chip to determine K D values with our inhibitors. All 13 tested compounds injected onto the EthR-coated chip produced unexpected SPR profiles characterized by negative values. No signal was recorded when inactive analogues were tested, nor when known EthR inhibitors were injected onto a chip functionalized with an EthR variant harboring a mutation known to block the entrance of ligand into the binding pocket.
The K D values deduced from the dose-response curves obtained with the studied ligands were compared with activities deduced using two other assays. K D 's appear nicely correlated with DT m values obtained from thermal shift assays (R 2 = 0.84), as well as with IC 50 values measured using an EthR/DNA SPR assay (R 2 = 0.81). Two conclusions emerge from these results. First, the relatively solid correlation emerging from these pairwise comparisons reinforces the evidence that the negative SPR signal recorded reflects specific and quantitative affinity between EthR and ligands. Second, an important question concerning the inhibition of the DNA-binding properties of EthR was about the relationship between the affinity of ligands for EthR and their effect on the DNA binding. With the actual assay, we have now demonstrated that the inhibition of the DNA-binding function of EthR (IC 50 ) by synthetic inhibitors is directly correlated with their affinity (K D ) for EthR.
SPR techniques have been extensively used to detect interactions between two biological objects [12] , assuming that the detected effect is due to refractive index changes mainly due to mass changes. Nevertheless, a growing number of teams have reported negative dose-dependent SPR signals [17] [18] [19] [20] tentatively attributed to structural changes in the receptor induced by small ligands or inhibitors. Our results revealed a good correlation between the observed negative, dose-dependent, SPR signal and the binding of our ligands to EthR.
In this work, we have tempted to identify what could explain such negative SPR signal. The influence of buffers, Me 2 SO, protein concentrations, and electrostatic parameters has been carefully examined and eventually ruled out, opening the hypothesis that the observed negative signal may reflect the structural changes resulting from the ligand/protein interaction. The structural changes in EthR and other TetR-type regulators mainly involve the two helix-turn-helix (HTH) motifs of the dimeric active protein [23] [24] [25] [26] [27] . Here, we propose that the negative SPR signal recorded for EthR upon ligand binding may be detected using a nonoriented functionalization of EthR to the biosensor. Changes in protein conformation upon ligand binding do not systematically translate in negative SPR signal [28] . One can imagine that a positive signal can also result from such changes, but this signal would be masked by what would be assigned to the change of mass on the chip. Various teams have observed equivalent negative SPR responses upon protein/ligand interactions [17] [18] [19] [20] .
Although not yet fully characterized and still under debate, this signal was hypothesized to reflect major changes in protein conformation resulting from ligand binding [18] . Crystallographic studies revealed that EthR is composed of two symmetrical ligand-binding sites and two mobile HTH motifs. These motifs are submitted to major structural reorganization upon ligand binding: whereas DNA architecture forces HTH motifs to adopt approximately a 34-Å center-to-center distance, the structure of the liganded form of EthR revealed a 52-Å center-to-center distance. Thus, the main structural modification endured by the protein upon ligand binding is of large amplitude (more than 15 Å), highly polarized, and peripheral [23] [24] [25] [26] [27] .
While the impact of the amplitude of the conformational change in SPR signal is not easily measurable or predictable, the detection of conformational changes by SPR could constitute an unexpected powerful functional screening method for the identification of allosteric inhibitors. In radioactive binding assays, for instance, small ligands that interact with the target are identified regardless of their capacity to induce conformation changes. In contrast, the negative SPR signal observed here informed us on both the binding constants and the inhibitory activity of EthR synthetic ligands, which opens new perspectives on the use of SPR to identify inhibitors of transcriptional regulators or of any liganddependent allosteric control of soluble proteins. 
